drugset / Trial / NCT02479555

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization

NCT02479555 ↗

Phase 2 Unknown 120 enrolled Mercator MedSystems, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, multi-center, randomized pilot study to document the effects of adventitial delivery of dexamethasone after balloon angioplasty of lesions below the knee in symptomatic patients with critical limb ischemia (CLI).

Timeline

Start
2016-01
Primary completion
2020-08
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 0.8 mg Other

Indications